SCHEMBL9909142

SCHEMBL9909142

CCCCCCCCCCNCC#N

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.57
ALDH1A1 P00352 1/20 0.57
EPHX1 P07099 6/20 0.46
ADH1B P00325 1/20 0.46
ADH1C P00326 1/20 0.46
ADH1A P07327 1/20 0.46
ADH4 P08319 1/20 0.46
ADH7 P40394 1/20 0.46
S1PR2 O95136 5/20 0.42
S1PR4 O95977 5/20 0.42
S1PR1 P21453 5/20 0.42
S1PR3 Q99500 5/20 0.42
S1PR5 Q9H228 1/20 0.42
THRB P10828 1/20 0.40
ZDHHC20 Q5W0Z9 1/20 0.38
ZDHHC2 Q9UIJ5 1/20 0.38
HRH4 Q9H3N8 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
DPP4 P27487 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7341567 1.00 TSHR (0.57) TSHRALDH1A1EPHX1ADH1BADH1C
SCHEMBL11659167 1.00 TSHR (0.57) TSHRALDH1A1EPHX1ADH1BADH1C
SCHEMBL5983908 1.00 TSHR (0.57) TSHRALDH1A1EPHX1ADH1BADH1C
SCHEMBL7742021 1.00 TSHR (0.57) TSHRALDH1A1EPHX1ADH1BADH1C
SCHEMBL5984690 1.00 TSHR (0.57) TSHRALDH1A1EPHX1ADH1BADH1C
SCHEMBL5279912 1.00 TSHR (0.57) TSHRALDH1A1EPHX1ADH1BADH1C
Hydrochloric Acid SCHEMBL5984618 0.98 TSHR (0.55) TSHRALDH1A1EPHX1ADH1BADH1C
Hydrochloric Acid SCHEMBL5595474 0.98 TSHR (0.55) TSHRALDH1A1EPHX1ADH1BADH1C
SCHEMBL3625621 0.97
SCHEMBL442358 0.90

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8198461-B2 Process for the preparation of 3-cyano-1,2,4-triazoles AMPAC FINE CHEMICALS LLC. (US) 2012-06-12 US disclosed
US-20090292122-A1 PROCESS FOR THE PREPARATION OF CYANO-SUBSTITUTED-NITROGEN-CONTAINING HETEROARYL COMPOUNDS AMPAC FINE CHEMICALS LLC (US) 2009-11-26 US disclosed
US-20090203737-A1 Pyrrole Derivatives as Positive Allosteric Modulators of Metabotropic Receptors ADDEX PHARMA SA (CH) 2009-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090292122-A1 PROCESS FOR THE PREPARATION OF CYANO-SUBSTITUTED-NITROGEN-CONTAINING HETEROARYL COMPOUNDS ASNS, NCL, NBAS TSHR 3448/4885ALDH1A1 3567/4885EPHX1 2002/4885
US-20090203737-A1 Pyrrole Derivatives as Positive Allosteric Modulators of Metabotropic Receptors GRM5, GRIK5, GRM2 TSHR 311/4885ALDH1A1 4261/4885EPHX1 3631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.